Healthcare -
Biotechnology - NASDAQ - US
$ 0.62
0.977 %
$ 64.4 M
Market Cap
-1.35
P/E
UNCY - CAPITAL EXPENDITURES
Capital Expenditures UNCY - Unicycive Therapeutics, Inc.
-12 K
LAST VALUE
35.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR